No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients

Tylicki L, Biedunkiewicz B, Rachon D, et al. Mediators of Inflammation, 2004.

View the abstract on PubMed

Study type
Controlled trial (non-randomized)
People studied
12 people
Population
Chronically hemodialyzed patients with peripheral arterial disease
Published
2004, Mediators of Inflammation
Identifiers
PMID 15770057, DOI 10.1080/09629350400014131
Group
Background science and mechanism studies

What the authors reported

In a controlled, single-blind, cross-over study of 12 hemodialysis patients, nine sessions of ozonated autohemotherapy produced no significant change in plasma C-reactive protein or interleukin-6 compared with nine sham (oxygen-only) autohemotherapy sessions.

What limits this result

Small sample of 12 patients in a single crossover study; a null result for these two inflammatory markers does not rule out other biological effects of ozone.

How ozone acts on blood and cells, how blood filters work, the laboratory and device-development studies behind the EBOO circuit, and studies that measure markers in the blood rather than how patients fare. None of these shows whether EBO2 helps patients. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.

How the study was done

Design
Controlled, single-blind, cross-over study
Setting
Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Poland
Read from
Read from the full text of the paper. Read on September 28, 2026.

Source: Abstract on PubMed

Study arms

Each group as the paper describes it.
GroupParticipantsWhat they received
Control: oxygen-only autohemotherapy12Nine sessions of autohemotherapy with blood exposure to oxygen, given first
Ozonated autohemotherapy12Nine sessions of ozonated autohemotherapy with an ozone concentration of 50 microg/ml, given after the control sessions (same patients)

Source: Abstract on PubMed

Procedure as reported

Ozone concentration
50 microg/mlnine sessions of ozonated autohemotherapy with an ozone concentration of 50 microg/ml
Blood volume
250 ml of the patients' blood per ozonated sessionDuring O3-AHT sessions, 250 ml of the patients’ blood was exposed ex vivo to an oxygen /ozone mixture
Sessions
Nine control sessions (oxygen only) followed by nine sessions of ozonated autohemotherapy (O3-AHT)At the beginning subjects received nine sessions of autohemotherapy with blood exposure to medical oxygen (AHT) as a control, followed by nine sessions of O3-AHT.

In the paper's own units, not converted.

Sources: Abstract on PubMed, Full text on Europe PMC, Full text on PubMed Central

What it measured

C-reactive protein
No statistical difference: baseline 1.53 +/- 1.01 mg/l; after nine control sessions 1.48 +/- 0.96 mg/l; after nine ozonated sessions 1.55 +/- 0.84 mg/l
Interleukin-6 serum concentration
No statistical difference: baseline 438 +/- 118 pg/ml; after nine control sessions 444 +/- 120 pg/ml; after nine ozonated sessions 466 +/- 152 pg/ml
CRP serum level against the normal range
In the normal range throughout the study in all patients
Completion of the protocol
All 12 patients who entered the study completed the protocol

Sources: Abstract on PubMed, Full text on Europe PMC, Full text on PubMed Central

Safety as reported

No patient demonstrated symptoms of acute infectious disease during the study

Source: Full text on Europe PMC

Where we cite this study

All studies we track · How the studies compare